Month: November 2023

Google in talks to invest in AI startup Character.AI

Reuters exclusively reported that Google is in talks to invest hundreds of millions of dollars in Character.AI, as the fast growing artificial intelligence chatbot startup seeks capital to train models and keep up with user demand.  The post Google in talks to invest in AI startup Character.AI appeared first on Reuters News Agency.
Read More

Russia’s Putin to stay in power past 2024 

Reuters reported that Vladimir Putin has decided to run in the March presidential election, a move that will keep him in power until least 2030, as the Kremlin chief feels he must steer Russia through the most perilous period in decades.  The post Russia’s Putin to stay in power past 2024  appeared first on Reuters […]
Read More

China’s clashing priorities behind rare money market distress

Reuters exclusively reported China’s attempts to keep the yuan from falling contributed to last week’s chaos in money markets, pointing to the pressure behind the scenes as Beijing tries to guide its economy and markets through a major slowdown. The post China’s clashing priorities behind rare money market distress appeared first on Reuters News Agency.
Read More

Swiss authorities, banks mull new rules to prevent bank runs  

Reuters was first to report that Swiss authorities and lenders, including UBS (UBSG.S), are discussing new measures to prevent bank runs after Credit Suisse’s rescue earlier this year, a move that could affect billions in deposits.  The post Swiss authorities, banks mull new rules to prevent bank runs   appeared first on Reuters News Agency.
Read More

Applied Materials under US criminal probe for shipments to China’s SMIC

Reuters was first to report that semiconductor equipment maker Applied Materials is under U.S. criminal investigation for potentially evading export restrictions on China’s top chipmaker SMIC. The largest U.S. semiconductor equipment maker is being probed by the Justice Department for sending equipment to SMIC via South Korea without export licenses. The news, which Bloomberg in […]
Read More

Activist investor Elliott targets drugmaker BioMarin 

Reuters exclusively reported that Activist investor Elliott Investment Management has built a stake in BioMarin Pharmaceutical (BMRN.O) and has been in discussions with the biotechnology company for months about its future. The hedge fund, which oversees some $60 billion in assets, has spent over $1 billion on the stake in BioMarin, which focuses on rare […]
Read More

Cigna explores shedding Medicare Advantage business 

Reuters was first to report that U.S. health insurer Cigna Group (CI.N) is exploring the sale of its Medicare Advantage business, which manages government health insurance for people aged 65 and older, a move that would mark a reversal of its expansion in the sector.   The post Cigna explores shedding Medicare Advantage business  appeared first […]
Read More